Third generation cephalosporins and piperacillin/tazobactam have distinct impacts on the microbiota of critically ill patients
Abstract Effective implementation of antibiotic stewardship, especially in critical care, is limited by a lack of direct comparative investigations on how different antibiotics impact the microbiota and antibiotic resistance rates. We investigated the impact of two commonly used antibiotics, third-g...
Enregistré dans:
Auteurs principaux: | Hasinika K. A. H. Gamage, Carola Venturini, Sasha G. Tetu, Masrura Kabir, Vineet Nayyar, Andrew N. Ginn, Belinda Roychoudhry, Lee Thomas, Mitchell Brown, Andrew Holmes, Sally R. Partridge, Ian Seppelt, Ian T. Paulsen, Jonathan R. Iredell |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/89ef1323acf544d9a6dfaafa7d3554be |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
SIMULTANEOUS DETERMINATION OF PIPERACILLIN AND TAZOBACTAM IN THE PHARMACEUTICAL FORMULATION TAZONAM® BY DERIVATIVE SPECTROPHOTOMETRY
par: TORAL,M. INÉS, et autres
Publié: (2012) -
Outpatient therapy with piperacillin/tazobactam using elastomeric pumps in patients with Pseudomonas aeruginosa infection
par: Jose Luis Lamas Ferreiro, et autres
Publié: (2021) -
Pharmacokinetics and outcome of tazobactam/piperacillin in Japanese patients undergoing low-flow continuous renal replacement therapy: dosage considerations
par: Kohama H, et autres
Publié: (2017) -
Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of bla TEM-1B
par: Alasdair T. M. Hubbard, et autres
Publié: (2020) -
Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in <named-content content-type="genus-species">Escherichia coli</named-content>
par: Lisa M. Schechter, et autres
Publié: (2018)